Taurine Analogues; A New Class of Therapeutics: Retrospect and Prospects
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
2021-2039
Author(s):
R. C. Gupta, T. Win and S. Bittner
Editorial [Hot Topic: Ion Channels as a Target for Drug Design )Executive Editor: Kwok-Keung Tai)]
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2669-2670
Author(s):
Kwok-Keung Tai
Physiology and Pharmacology of Two-Pore Domain Potassium Channels
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2717-2736
Author(s):
Donghee Kim
Ion Channel Defects in Idiopathic Epilepsies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2737-2752
Author(s):
Holger Lerche, Yvonne G. Weber, Karin Jurkat-Rott and Frank Lehmann-Horn
Subtype-Selective Noncompetitive Modulators of Metabotropic Glutamate Receptor Subtype 1 (mGluR1)
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
859-867
Author(s):
Mark E. Layton
Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 2 (mGluR2)
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
869-884
Author(s):
Michael T. Rudd and John A. McCauley
Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System
Journal:
Current Topics in Medicinal Chemistry
Volume:
5
Page:
885-895
Author(s):
Michael J. Marino, J. F. Hess and Nigel Liverton
Role of Nitric Oxide and Calpain Activation in Neuronal Death and Survival
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
319-324
Author(s):
I. M. Araujo and C. M. Carvalho
The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
331-347
Author(s):
A. P. Silva, S. Xapelli, E. Grouzmann and C. Cavadas
Inflammation and Neurogenesis in Temporal Lobe Epilepsy
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
4
Page:
349-360
Author(s):
L. Bernardino, R. Ferreira, A. J. Cristovao, F. Sales and J. O. Malva